Lung Cancer Clinical Trials in Albuquerque, NM

Lung Cancer Clinical Trials in Albuquerque, NM

View the best 10 lung cancer medical studies in Albuquerque, New Mexico. Access promising new therapies by applying to a Albuquerque-based Lung Cancer clinical trial.

Trials in Albuquerque, New Mexico

Here are the top 10 medical studies for lung cancer in Albuquerque, New Mexico

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: February 19th, 2025

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Hypofractionated Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial is testing the safety and effectiveness of a new cancer treatment that involves radiation therapy followed by immunotherapy with atezolizumab.
Image of University of South Alabama /ID# 212939 in Mobile, United States.

Telisotuzumab Vedotin

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests telisotuzumab vedotin, a treatment that targets and kills cancer cells, in NSCLC patients with high c-Met levels. It aims to find the best patient group for this therapy and evaluate its safety and effectiveness. Telisotuzumab vedotin is a specialized treatment targeting c-Met-overexpressing tumor cells, and it has been evaluated in various studies for its safety and efficacy in treating advanced solid tumors, including non-small cell lung cancer.
Image of Alaska Oncology and Hematology in Anchorage, United States.

Docetaxel +1 More

Anti-microtubule agent

Recruiting2 awardsPhase 3
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Stereotactic Body Radiotherapy +2 More

Radiation

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of Research Site in Duarte, United States.

AZD8205

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called AZD8205 to see if it can help treat advanced or spreading solid tumors. The study includes patients whose cancer is advanced or has spread and may not respond to current treatments. AZD8205 might work by stopping or slowing down the growth of cancer cells.
Image of Research Site - Orange City in Orange City, United States.

HLX10

Monoclonal Antibodies

Recruiting3 awardsPhase 3
This trial is testing two different treatment combinations for patients with extensive-stage small cell lung cancer who have not received any prior treatment. One group will receive a new drug called Serplulimab along with standard chemotherapy, while the other group will receive an existing drug called Atezolizumab with the same chemotherapy. Both immunotherapy drugs aim to help the immune system fight cancer, and the chemotherapy drugs work by killing cancer cells. Atezolizumab has been shown to improve survival in small-cell lung cancer when combined with chemotherapy, changing the standard first-line therapy.
Image of Mercy Hospital Fort Smith in Fort Smith, United States.

Afatinib Dimaleate

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2 & 3
This trial is studying afatinib dimaleate with or without cetuximab to treat patients with non-small cell lung cancer that has EGFR mutations.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Durvalumab

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is testing whether adding durvalumab to standard chemoradiation followed by additional durvalumab can extend patients life and/or prevent the tumor from coming back compared to the usual approach of chemoradiation alone followed by durvalumab.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.

Popular Filters

Age 65+
Phase 3
< 50 mile distance
No Placebo

Phase 3 Trials

Birmingham, Alabama

Checkpoint Inhibitor

Nivolumab +/- Ipilimumab for Lung Cancer

Recruiting2 awardsPhase 3
Tucson, Arizona
This trial is testing nivolumab with or without ipilimumab to see if it can treat patients with squamous cell lung cancer that has come back after previous treatment.
Birmingham, Alabama

Radiation

Whole-Brain Radiation Therapy for Small Cell Lung Cancer

Recruiting1 awardPhase 2 & 3
Tucson, Arizona
This trial is studying whether whole-brain radiation therapy is more effective with or without hippocampal avoidance in treating patients with small cell lung cancer.
Fort Smith, Arkansas

Tyrosine Kinase Inhibitor

Afatinib +/− Cetuximab for Non-Small Cell Lung Cancer

Recruiting1 awardPhase 2 & 3
Durango, Colorado
This trial is studying afatinib dimaleate with or without cetuximab to treat patients with non-small cell lung cancer that has EGFR mutations.
Birmingham, Alabama

Radiation

Surgery or High-Dose Radiation for Metastatic Breast Cancer

Recruiting1 awardPhase 2 & 3
Albuquerque, New Mexico
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Birmingham, Alabama

Tyrosine Kinase Inhibitor

Crizotinib for Non-Small Cell Lung Cancer

Recruiting2 awardsPhase 3
Scottsdale, Arizona
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Birmingham, Alabama

Alkylating agents

Radiation + Chemotherapy for Small Cell Lung Cancer

Recruiting2 awardsPhase 3
Tucson, Arizona
This trial is testing different radiation therapy regimens to see which is more effective in treating patients with limited-stage small cell lung cancer when given together with chemotherapy.

Trials With No Placebo

Birmingham, Alabama

Anti-metabolites

Maintenance Chemotherapy for Lung Cancer

Recruiting1 awardPhase 2
Colorado Springs, Colorado
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Birmingham, Alabama

Checkpoint Inhibitor

Nivolumab +/- Ipilimumab for Lung Cancer

Recruiting2 awardsPhase 3
Tucson, Arizona
This trial is testing nivolumab with or without ipilimumab to see if it can treat patients with squamous cell lung cancer that has come back after previous treatment.
Birmingham, Alabama

Radiation

Whole-Brain Radiation Therapy for Small Cell Lung Cancer

Recruiting1 awardPhase 2 & 3
Tucson, Arizona
This trial is studying whether whole-brain radiation therapy is more effective with or without hippocampal avoidance in treating patients with small cell lung cancer.
Birmingham, Alabama

Kinase Inhibitor

Targeted Therapy for Cancer

Recruiting1 awardPhase 2
Scottsdale, Arizona
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Fort Smith, Arkansas

Tyrosine Kinase Inhibitor

Afatinib +/− Cetuximab for Non-Small Cell Lung Cancer

Recruiting1 awardPhase 2 & 3
Durango, Colorado
This trial is studying afatinib dimaleate with or without cetuximab to treat patients with non-small cell lung cancer that has EGFR mutations.
Birmingham, Alabama

Radiation

Surgery or High-Dose Radiation for Metastatic Breast Cancer

Recruiting1 awardPhase 2 & 3
Albuquerque, New Mexico
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.

View More Related Trials

Screening Platform

Carboplatin +4 More

Carboplatin +1 More

VMD-928

Telisotuzumab Vedotin

Cabozantinib S-malate

HLX10

Thoracotomy +1 More

AZD8205

N-803 (ALT-803) +1 More

Tislelizumab +2 More

Sotorasib

Datopotamab Deruxtecan +1 More

Hypofractionated Radiation Therapy

Nivolumab +1 More

Selpercatinib

Nivolumab +2 More

Fractionated Stereotactic Radiation Therapy +1 More

Pembrolizumab

Docetaxel +1 More

Sotorasib +1 More

Paclitaxel +4 More

Cemiplimab +1 More

FSRS +1 More

Chemotherapy +2 More

Pembrolizumab +2 More

Atezolizumab +1 More

View more lung-cancer clinical trials albuquerque

See more medical studies focusing on lung-cancer albuquerque

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top